JCDSA  Vol.4 No.1 , February 2014
Clinical Evaluation of Moisturizers with Physiological Analysis of Stratum Corneum TARC and TSLP
Abstract

To verify the usefulness of moisturizers, a multi-center study was conducted on patients with atopic dermatitis who visited 3 university hospitals in Japan between November 2009 and March 2012. Thirty-seven patients with dry skin and stable symptoms who were receiving topical and oral treatments were given moisturizers for 8 weeks. The moisturizers contained components such as glycerin and seawater minerals in 3 forms: lotion, emulsion, and cream. The moisturizers were chosen by physicians based on the degree of dryness of the patients’ skin. In addition to observing the skin condition of the entire body, high-frequency conductance as a parameter of skin surface hydration and transepidermal water loss (TEWL) in the buccal region and the medial side of the forearm were measured, and those of the back were used for comparison. Furthermore, stratum corneum levels of thymic stromal lymphopoietin (TSLP) and thymus and activation-regulated chemokine (TARC), both of which were objective parameters for atopic dermatitis skin lesion severity, were analyzed using the tape stripping method. At the beginning of the study, TSLP showed a correlation with skin symptoms (dryness, itching) and high-frequency conductance, whereas TARC showed a correlation with skin symptoms (erythema, dryness, itching) and TEWL. In addition, a correlation was noted among TSLP, TARC, and itching. At the end of the study, erythema, dryness, itching, TEWLTSLP, and TARC were significantly reduced, whereas high-frequency conductance was significantly increased. The moisturizers clearly improved the dry skin symptoms of these patients with atopic dermatitis and improved the physiology of their sensitive and damaged skin. These findings also support the involvement of cytokines/chemokines in the pathogenesis of atopic dermatitis lesions.


Cite this paper
S. Fukushima, E. Morita, M. Tanioka, Y. Miyachi, Y. Murakami, H. Matsunaka and H. Ihn, "Clinical Evaluation of Moisturizers with Physiological Analysis of Stratum Corneum TARC and TSLP," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 4 No. 1, 2014, pp. 37-43. doi: 10.4236/jcdsa.2014.41006.
References

[1]   J. Callen, S. Chamlin, L. F. Eichenfield, C. Ellis, M. Girardi, M. Goldfarb, et al., “A Systematic Review of the Safety of Topical Therapies for Atopic Dermatitis,” British Journal of Dermatology, Vol. 156, No. 2, 2007, pp. 203-221. http://dx.doi.org/10.1111/j.1365-2133.2006.07538.x

[2]   D. Y. Leung and T. Bieber, “Atopic Dermatitis,” The Lancet, Vol. 361, No. 9352, 2003, pp. 151-160. http://dx.doi.org/10.1016/S0140-6736(03)12193-9

[3]   G. Imokawa, A. Abe, K. Jin, Y. Higaki, M. Kawashima and A. Hidano, “Decreased Level of Ceramides in Stratum Corneum of Atopic Dermatitis: An Etiologic Factor in Atopic Dry Skin?” The Journal of Investigative Dermatology, Vol. 96, No. 4, 1991, pp. 523-526. http://dx.doi.org/10.1111/1523-1747.ep12470233

[4]   J. Yamaguchi, M. Aihara, Y. Kobayashi, T. Kambara and Z. Ikezawa, “Quantitative Analysis of Nerve Growth Factor (NGF) in the Atopic Dermatitis and Psoriasis Horny Layer and Effect of Treatment on NGF in Atopic Dermatitis,” Journal of Dermatological Science, Vol. 53, No. 2, 2009, pp. 48-54. http://dx.doi.org/10.1016/j.jdermsci.2008.08.011

[5]   K. Tamaki, T. Kakinuma, H. Saeki, T. Horikawa, Y. Kataoka, T. Fujisawa, et al., “Serum Levels of CCL17/ TARC in Various Skin Diseases,” The Journal of Dermatology, Vol. 33, No. 4, 2006, pp. 300-302. http://dx.doi.org/10.1111/j.1346-8138.2006.00072.x

[6]   T. Fujisawa, M. Nagao, Y. Hiraguchi, H. Katsumata, H. Nishimori, K. Iguchi, et al., “Serum Measurement of Thymus and Activation-Regulated Chemokine/CCL17 in Children with Atopic Dermatitis: Elevated Normal Levels in Infancy and Age-Specific Analysis in Atopic Dermatitis,” Pediatric Allergy and Immunology, Vol. 20, No. 7, 2009, pp. 633-641.
http://dx.doi.org/10.1111/j.1399-3038.2009.00851.x

[7]   F. J. Smith, et al., “Loss-of-Function Mutations in the Gene Encoding Filaggrin Cause Ichthyosis Vulgaris,” Nature Genetics, Vol. 38, No. 3, 2006, pp. 337-342. http://dx.doi.org/10.1038/ng1743

[8]   T. Nomura, M. Akiyama, A. Sandilands, I. Nemoto-Hasebe, K. Sakai, A. Nagasaki, T. Nomura, et al., “Prevalent and Rare Mutations in the Gene Encoding Filaggrin in Japanese Patients with Ichthyosis Vulgaris and Atopic Dermatitis,” The Journal of Investigative Dermatology, Vol. 129, No. 5, 2009, pp. 1302-1305. http://dx.doi.org/10.1038/jid.2008.372

[9]   M. Portugal-Cohen, M. Oron, E. Merrik, Z. Ma’or, D. Ben-Amitai, H. Yogev, et al., “A Dead Sea Water-Enriched Body Cream Improves Skin Severity Scores in Children with Atopic Dermatitis,” Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 1, No. 3, 2011, pp. 71-78.
http://dx.doi.org/10.4236/jcdsa.2011.13012

[10]   H. Saeki, M. Furue, F. Furukawa, M. Hide, M. Ohtsuki, I. Katayama, et al., “Guidelines for Management of Atopic Dermatitis,” The Journal of Dermatology, Vol. 36, No. 10, 2009, pp. 563-577.
http://dx.doi.org/10.1111/j.1346-8138.2009.00706.x

[11]   K. Kikuchi, H. Kobayashi, K. O’goshi and H. Tagami, “Impairment of Skin Barrier Function Is Not Inherent in Atopic Dermatitis Patients: A Prospective Study Conducted in Newborns,” Pediatric Dermatology, Vol. 23, No. 2, 2006, pp. 109-113. http://dx.doi.org/10.1111/j.1525-1470.2006.001 91.x

[12]   E. L. Simpson, T. M. Berry, P. A. Brown and J. M. Hanifin, “A Pilot Study of Emollient Therapy For the Primary Prevention of Atopic Dermatitis,” Journal of the American Academy of Dermatology, Vol. 63, No. 4, 2010, pp. 587-593. http://dx.doi.org/10.1016/j.jaad.2009.11.011

[13]   J. Kawasaki, H. Ushio, H. Kinoshita, T. Fukai, F. Niyonsaba, T. Takai, et al., “Viral Infection Induces Thymic Stromal Lymphopoietin (TSLP) in Human Keratinocytes,” Journal of Dermatological Science, Vol. 62, No. 2, 2011, pp. 131-134. http://dx.doi.org/10.1016/j.jdermsci.2011.02.005

[14]   Z. Zhu, M. H. Oh, J. Yu, Y. J. Liu and T. Zheng, “The Role of TSLP in IL-13-Induced Atopic March,” Scientific Reports, Vol. 1, No. 23, 2011, pp. 1-11. http://dx.doi.org/10.1038/srep00023

[15]   Y. Sano, K. Masuda, R. Tamagawa-Mineoka, H. Matsunaka, Y. Murakami, R. Yamashita, et al., “Thymic Stromal Lymphopoietin Expression Is Increased in the Horny Layer of Patients with Atopic Dermatitis,” Clinical & Experimental Immunology, Vol. 171, No. 3, 2013, pp. 330-337.
http://dx.doi.org/10.1111/cei.12021

[16]   E. Morita, H. Takahashi, H. Niihara, I. Dekio, Y. Sumikawa, Y. Murakami, et al., “Stratum Corneum TARC Level Is a New Indicator of Lesional Skin Inflammation in Atopic Dermatitis,” Allergy, Vol. 65, No. 9, 2010, pp. 1166-1172. http://dx.doi.org/10.1111/j.1398-9995.2010.02361.x

 
 
Top